Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and Safety of Daptomycin (With or Without Rifampin) in the Treatment of Staphylococcal Hip, Knee and Shoulder Prosthetic Joint Infection.

Next Previous
Trial Profile

Efficacy and Safety of Daptomycin (With or Without Rifampin) in the Treatment of Staphylococcal Hip, Knee and Shoulder Prosthetic Joint Infection.

Status: Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Jan 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Daptomycin (Primary) ; Rifampicin
  • Indications Bone and joint infections; Methicillin-resistant Staphylococcus aureus infections; Staphylococcal infections
  • Focus Therapeutic Use
  • Acronyms Dapto-Studie

Most Recent Events

  • 25 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
  • 25 Jun 2012 Planned End Date changed from 1 Jun 2011 to 1 Jun 2016 as reported by ClinicalTrials.gov.
  • 25 Jun 2012 Planned initiation date changed from 1 Sep 2010 to 1 Jun 2012 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top